Product Information
PHENAZOPYRIDINE HCL 95 MG TAB is a generic product labeled by Rugby Laboratories, priced at $0.1316 per EA under NDC 00536141107. Its NADAC has been published 124 times since May 22, 2024.
Strength
95 mg/1
Manufacturer
Rugby LaboratoriesNDC
00536141107
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PHENAZOPYRIDINE HYDROCHLORIDEApproval Type
Unapproved
On Market Since
12/7/2023
Price Statistics
The NADAC for PHENAZOPYRIDINE HCL 95 MG TAB has been published 124 times since May 22, 2024, and over the history we have for it it has risen 11.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1316 per EA |
|---|---|
| All-time high | $0.1368 (Apr 15, 2026) |
| All-time low | $0.1179 (May 22, 2024) |
| 52-week high | $0.1368 |
| 52-week low | $0.1264 |
| Median price | $0.1270 |
| Average price | $0.1266 |
| Largest weekly change | -4.1% (Sep 18, 2024) |
| Weeks tracked | 124 |
| Tracking since | May 22, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rugby Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PHENAZOPYRIDINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PHENAZOPYRIDINE HCL 95 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for PHENAZOPYRIDINE HCL 95 MG TAB, manufactured by Rugby Laboratories, is $0.1316 per EA (NDC 00536141107), effective Sep 30, 2026.
How has the price of PHENAZOPYRIDINE HCL 95 MG TAB changed over time?
Over the history we have for it, the NADAC for PHENAZOPYRIDINE HCL 95 MG TAB has risen 11.6%. It has been tracked across 124 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for PHENAZOPYRIDINE HCL 95 MG TAB?
Since May 22, 2024, the NADAC for PHENAZOPYRIDINE HCL 95 MG TAB has ranged from a low of $0.1179 (May 22, 2024) to a high of $0.1368 (Apr 15, 2026), with a median of $0.1270 per EA.
Are there cheaper alternatives to PHENAZOPYRIDINE HCL 95 MG TAB?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HM URINARY PAIN RLF 95 MG TAB, is $0.1189 per EA — about 10% below PHENAZOPYRIDINE HCL 95 MG TAB.
Who manufactures PHENAZOPYRIDINE HCL 95 MG TAB?
PHENAZOPYRIDINE HCL 95 MG TAB (NDC 00536141107) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.